Quick Answer
Pulmonx Corp reported Long-Term Debt of $36.99 million for fiscal year 2025.
Pulmonx Corp Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2025 | $36.99M | +8.8% |
| 2024 | $34.00M | -3.1% |
| 2023 | $35.09M | +103.6% |
| 2022 | $17.23M | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $37.02M | -0.3% | +0.0% |
| June 30, 2025 | $37.01M | -0.3% | +25.9% |
| March 31, 2025 | $29.39M | -8.2% | -13.6% |
| December 31, 2024 | $34.00M | -3.1% | -8.4% |
| September 30, 2024 | $37.14M | -0.0% | +0.1% |
| June 30, 2024 | $37.11M | -0.1% | +16.0% |
| March 31, 2024 | $32.00M | -13.9% | -8.8% |
| December 31, 2023 | $35.09M | +103.6% | -5.6% |
- Pulmonx Corp showed an increase of +8.8% in Long-Term Debt compared to the prior fiscal year.
- Over the 2022–2025 period, Pulmonx Corp’s long-term debt has grown by 114.6% (from $17.23 million to $36.99 million).
- The most recent figure is from Pulmonx Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: